Literature DB >> 6183259

Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins.

Y L Marcel, M Hogue, R Theolis, R W Milne.   

Abstract

The reactivity of a series of monoclonal antibodies directed against human low density lipoproteins (LDL) has been tested with hepatic and intestinal apolipoprotein B (apo-B) termed B-100 and B-48, respectively (Kane, J. P., Hardman, D. A., and Paulus, H. E. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 2465-2469). Whereas those antibodies that have been previously shown to recognize determinants close to the LDL receptor recognition site reacted only with B-100, two antibodies specific for other regions of apo-B reacted with both B-100 and B-48. Therefore, it is probable that sequence homologies exist between the two proteins and it must be considered that all or parts of the B-48 sequence may be contained within that of B-100. The specificity of the reaction of these antibodies with proteins designated B-74 and B-26 supports the concept that they represent complementary fragments of B-100. The present results have been incorporated in a theoretical map of the antigenic determinants recognized by these antibodies on the LDL apo-B.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Isolation of a cDNA clone encoding the amino-terminal region of human apolipoprotein B.

Authors:  A A Protter; D A Hardman; J W Schilling; J Miller; V Appleby; G C Chen; S W Kirsher; G McEnroe; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2.

Authors:  S W Law; K J Lackner; A V Hospattankar; J M Anchors; A Y Sakaguchi; S L Naylor; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 4.  Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.

Authors:  C M Ballantyne; L Chan; J Guevara; J D Morrisett; M P Mims; A M Gotto
Journal:  Tex Heart Inst J       Date:  1994

5.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.

Authors:  T L Innerarity; S G Young; K S Poksay; R W Mahley; R S Smith; R W Milne; Y L Marcel; K H Weisgraber
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Human apolipoprotein B: identification of cDNA clones and characterization of mRNA.

Authors:  M Mehrabian; V N Schumaker; G C Fareed; R West; D F Johnson; T Kirchgessner; H C Lin; X B Wang; Y H Ma; E Mendiaz
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

7.  Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

Authors:  Y L Marcel; R McPherson; M Hogue; H Czarnecka; Z Zawadzki; P K Weech; M E Whitlock; A R Tall; R W Milne
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.

Authors:  A J Lusis; R West; M Mehrabian; M A Reuben; R C LeBoeuf; J S Kaptein; D F Johnson; V N Schumaker; M P Yuhasz; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

Authors:  R W Milne; P K Weech; L Blanchette; J Davignon; P Alaupovic; Y L Marcel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

Authors:  S G Young; S J Bertics; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.